Pre-procedural antibody testing for SARS-CoV-2 in the routine endoscopic practice.
Rev Esp Enferm Dig
; 113(2): 116-118, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-954242
ABSTRACT
METHODS:
a retrospective multicenter cohort study was performed of all endoscopic procedures performed between April 27 and June 15, 2020. A screening questionnaire (SQ) was performed with patients three days prior to the procedure and 14 days after. Furthermore, a serologic SARS-CoV-2 test was performed 48 hours before.RESULTS:
two hundred and eleven consecutive patients with endoscopic procedures were included. No patients had a positive SQ, either on entry to the study or 14 days later. Only four patients (1.9 % [95 % CI 0.07-4.8 %]) were positive for antibodies.CONCLUSION:
the pre-endoscopy seroprevalence of SARS-CoV-2 is low in this cohort. Pre-procedural SARS-CoV-2 antibody testing does not add any benefit over clinical SQ to identify active COVID-19 patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Endoscopy, Gastrointestinal
/
COVID-19 Serological Testing
/
COVID-19
Type of study:
Cohort study
/
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Rev Esp Enferm Dig
Journal subject:
Gastroenterology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS